Sue L Currie

Summary

Country: USA

Publications

  1. ncbi request reprint A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus
    Sue L Currie
    Department of Medicine, University of California San Francisco, San Francisco, CA 94121, USA
    Drug Alcohol Depend 93:148-54. 2008
  2. doi request reprint Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study
    Helen S Yee
    Gastroenterology Section, Department of Veterans Affairs Medical Center VAMC, 4150 Clement Street 111B, San Francisco, CA 94121, USA
    Dig Dis Sci 56:2439-48. 2011
  3. ncbi request reprint Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?
    Karen H Seal
    VA Medical Center, San Francisco, CA 94121, USA
    J Clin Gastroenterol 41:199-205. 2007
  4. ncbi request reprint National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection
    Edmund J Bini
    VA New York Harbor Healthcare System and NYU School of Medicine, New York, NY, USA
    J Clin Gastroenterol 40:732-9. 2006
  5. ncbi request reprint Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office
    Helen S Yee
    Department of Veterans Affairs Hepatitis C Resource Center Program, San Francisco, California, USA
    Am J Gastroenterol 101:2360-78. 2006
  6. ncbi request reprint Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans
    Ke Qin Hu
    Loma Linda VA Medical Center, Loma Linda, CA, USA
    Dig Dis Sci 52:570-8. 2007
  7. ncbi request reprint Hepatitis C virus infection among prisoners in the California state correctional system
    Rena K Fox
    Division of General Internal Medicine, University of California San Francisco, 94105, USA
    Clin Infect Dis 41:177-86. 2005

Collaborators

Detail Information

Publications7

  1. ncbi request reprint A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus
    Sue L Currie
    Department of Medicine, University of California San Francisco, San Francisco, CA 94121, USA
    Drug Alcohol Depend 93:148-54. 2008
    ..Many HCV-infected persons with recent or ongoing injection drug use (IDU) do not receive HCV treatment due to the perceived risk of HCV reinfection. There are few prospective studies investigating HCV reinfection among IDUs...
  2. doi request reprint Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study
    Helen S Yee
    Gastroenterology Section, Department of Veterans Affairs Medical Center VAMC, 4150 Clement Street 111B, San Francisco, CA 94121, USA
    Dig Dis Sci 56:2439-48. 2011
    ..As such, CIFN/RBV use and efficacy in clinical practice were evaluated within the Department of Veterans Affairs (VA), the largest national, integrated system for HCV care...
  3. ncbi request reprint Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?
    Karen H Seal
    VA Medical Center, San Francisco, CA 94121, USA
    J Clin Gastroenterol 41:199-205. 2007
    ..Many patients with a history of injection drug use (IDU) are excluded from hepatitis C virus (HCV) treatment. This prospective multicenter study aimed to determine the impact of IDU history on HCV treatment candidacy and outcomes...
  4. ncbi request reprint National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection
    Edmund J Bini
    VA New York Harbor Healthcare System and NYU School of Medicine, New York, NY, USA
    J Clin Gastroenterol 40:732-9. 2006
    ..Although HIV testing is recommended for persons with hepatitis C virus (HCV) infection who are at risk for HIV, little is known about HIV testing in this population...
  5. ncbi request reprint Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office
    Helen S Yee
    Department of Veterans Affairs Hepatitis C Resource Center Program, San Francisco, California, USA
    Am J Gastroenterol 101:2360-78. 2006
    ....
  6. ncbi request reprint Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans
    Ke Qin Hu
    Loma Linda VA Medical Center, Loma Linda, CA, USA
    Dig Dis Sci 52:570-8. 2007
    ..We found that steatosis is independently associated with stage III-IV fibrosis. However, only HCV genotype, and not steatosis, obesity, or stage III-IV fibrosis, was associated with SVR to interferon alpha-2b and ribavirin treatment...
  7. ncbi request reprint Hepatitis C virus infection among prisoners in the California state correctional system
    Rena K Fox
    Division of General Internal Medicine, University of California San Francisco, 94105, USA
    Clin Infect Dis 41:177-86. 2005
    ..Understanding the risk factors of HCV infection among prisoners could help improve HCV interventions...